KORU Medical Systems, Inc. (KRMD)
Market Cap | 183.71M |
Revenue (ttm) | 29.04M |
Net Income (ttm) | -8.53M |
Shares Out | 46.39M |
EPS (ttm) | -0.19 |
PE Ratio | n/a |
Forward PE | 188.68 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 3,336 |
Open | 3.99 |
Previous Close | 4.00 |
Day's Range | 3.96 - 4.00 |
52-Week Range | 1.82 - 4.48 |
Beta | 0.40 |
Analysts | Strong Buy |
Price Target | 4.25 (+6.78%) |
Earnings Date | Aug 2, 2023 |
About KRMD
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales... [Read more]
Financial Performance
In 2022, KRMD's revenue was $27.90 million, an increase of 18.76% compared to the previous year's $23.49 million. Losses were -$8.66 million, 89.8% more than in 2021.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price forecast is $4.25, which is an increase of 6.78% from the latest price.
News

KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commerci...

KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializat...

KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commerci...

KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializat...

KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development, manufacturing, and commercialization of in...

KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializ...

KORU Medical Systems to Participate in Upcoming Investor Conferences
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializ...

KORU Medical Systems Announces 2022 Third Quarter Financial Results
MAHWAH, N.J.

KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals
MAHWAH, N.J.

KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022
MAHWAH, N.J.

KORU Medical Systems to Participate in Upcoming Industry Conferences
MAHWAH, N.J.

KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
MAHWAH, N.J.

KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion s...

KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home...

KORU Medical Systems Announces 2022 Second Quarter Financial Results
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commerci...

KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home...

KORU Medical Systems Announces 2022 First Quarter Financial Results
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manu...

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manu...

KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

KORU Medical Systems Appoints Brian Case As Chief Technology Officer
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manu...

CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
CHESTER, N.Y.--(BUSINESS WIRE)--First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the ...

KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2021
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of in...